Skip to content

Brain Works

Facebook
Twitter
LinkedIn
Ariana Gatt talks about pharma, fruit fly research, and Alzheimer’s and Parkinson’s disease.
Ariana Gatt
Ariana Gatt

In 2008 I graduated from the University of Malta with a B.Sc. in Chemistry and Biology. Then, I worked as an R&D chemist with SoleaPharma Ltd., which also allowed me to spend six months training in pharmaceutical chemistry in Spain at the mother company Gadea Pharmaceuticals. I learned a lot in this period—not only lab work skills, but also about the whole business and industry. However, after two years working in the pharma industry, I realised I still wanted to further my studies.

I had always dreamed of studying abroad and experiencing a university in another country, so I applied for Masters courses in the UK. I had realised by this point that I wanted to carry out biomedical research, with a particular interest in neuroscience. I read for an M.Sc. in molecular sciences and biomedical research at King’s College London, funded by an EU funded STEPS scholarship. The M.Sc. opened the door for a Ph.D. in the same lab, which I am currently finishing .

For my Ph.D., I am investigating the role of mitochondrial dysfunction in neurodegeneration. Mitochondria produce energy for our cells. They are especially important in brain cells, since the brain uses 20% of the body’s energy. In neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease, mitochondria stop functioning properly, leading to a loss of energy in the brain. This may contribute to the eventual death of brain cells. In my project, I am modelling the loss of mitochondrial function in fruit flies (Drosophila melanogaster) to understand the early stages of neurodegeneration. Fruit flies and humans share many genes and therefore, studying the genes involved in mitochondrial dysfunction in the fly allows us to find potential early treatments to prevent irreparable damage in human neurodegenerative diseases. 

Part of my Ph.D. focuses on studying human tissue from patients who have died from these diseases. These post-mortem tissue samples are obtained from UK brain banks. I am using them to identify genes that are involved in these diseases. 

I don’t know what lies ahead in my career path. I hope it will involve answering questions regarding brain function and helping to solve the many puzzles related to neurodegenerative disease. 

Author

More to Explore

Malta and Uzbekistan: A Tale of Two Countries

A joint effort between UM’s Department of Translation, Terminology and Interpreting Studies and Prof. Gulnoza Odilova, who heads the Department of Theory and Practice of Translation at Kimyo International University of Tashkent, has led to the production of Rakkonti mill-Bogħod, Stejjer Qosra mill-Użbekistan, published by Kite Group in March 2025. Funded by the 2024 Malta Book Fund, Prof. Sergio Portelli and Dr Claudine Borg edited the translation of ten classic stories of Uzbek heritage and folklore into Maltese.

Xjenza Malta and TÜBİTAK Support Five New Transnational R&I Projects

A kick-off meeting, organised by Xjenza Malta on 28 July 2026, marked the launch of five new research and innovation (R&I) projects that foster greater collaboration between Malta-based researchers and partners in Türkiye. The projects, awarded funding under the fifth Xjenza Malta–TÜBİTAK Joint Call for Research and Innovation R&I Proposals (2025), cover a range of research areas, including aviation, health, water management, and farming systems.

Should Universities Cross-Pollinate Subjects in an Uncertain World?

Technology is seeping into research and academic writing, and the shift towards labour-market facilitation rather than academic curation is changing the knowledge and learning landscape. Such shifts, however, are set against cultural biases in subjects and traditional, outdated academic structures, even as universities try to evolve.

Comments are closed for this article!